ダウンロード数: 938
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| 59_213.pdf | 645.27 kB | Adobe PDF | 見る/開く |
| タイトル: | 腎盂尿管癌術後, ピラルビシン膀胱注入療法による術後膀胱内再発予防効果の検討 |
| その他のタイトル: | Effect of Prophylactic Intravesical Instillation of Pirarubicin to Prevent Recurrent Bladder Tumors Following Nephroureterectomy for Upper Urinary Tract Cancer |
| 著者: | 長島, 政純  荒木, あずみ 柳澤, 昌宏 小宮, 敦 高野, 哲三 村上, 貴之 池田, 伊知郎 |
| 著者名の別形: | Nagashima, Masazumi Araki, Azumi Yanagisawa, Masahiro Komiya, Atsushi Takano, Tetsuzo Murakami, Takayuki Ikeda, Ichiro |
| キーワード: | Following upper urinary tract cancer Prophylactic intravesical instillation |
| 発行日: | Apr-2013 |
| 出版者: | 泌尿器科紀要刊行会 |
| 誌名: | 泌尿器科紀要 |
| 巻: | 59 |
| 号: | 4 |
| 開始ページ: | 213 |
| 終了ページ: | 216 |
| 抄録: | We retrospectively evaluated 23 patients who had been administered pirarubicin by intravesical instillation once weekly for 5 weeks, after undergoing surgery for upper urinary tract cancer between May 2003 and October 2008. We compared their clinical records with those of 19 patients with upper urinary tract cancer subjected to nephroureterectomy between 1998 and 2008, and who did not receive intravesical instillation of pirarubicin. This prophylactic therapy was well tolerated and contributed to reduce the rate of bladder recurrence. The non-recurrence rate at 2 years was 87.0% in the instillation group and 68.4% in the non-instillation group (P＝0.0025). The overall analysis of the study population did not reveal any statistically significant risk factors of bladder recurrence. |
| 著作権等: | 許諾条件により本文は2014-05-01に公開 |
| URI: | http://hdl.handle.net/2433/173722 |
| PubMed ID: | 23635455 |
| 出現コレクション: | Vol.59 No.4 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。